Urine test improves non-invasive detection of prostate cancer

Shorter radiation therapy after prostate surgery safe, UCLA study finds

For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a vital role in reducing the risk of recurrence.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Quest Diagnostics report shows oncologists see more advanced cancers, say current tests not catching recurrence early enough

According to a recent report, “The Cancer Paradox: Oncologists’ Perspectives on Barriers to Advanced Cancer Care and Recurrence Monitoring,” oncologists believe they are seeing more and more patients with advanced cancers, and that screening barriers are the leading reason why. They worry that current tests may not catch cancer recurrence early enough.

May 16, 2025

Vol.51 No.19

Clinical Roundup

AI mapping technology outperforms MRI in predicting prostate cancer spread, study shows

Avenda Health has announced study results showing that its cancer mapping tool, Unfold AI, predicts cancer spread more accurately than MRI.

May 02, 2025

Vol.51 No.17

Clinical Roundup

Cleveland Clinic Abu Dhabi performs first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer

Cleveland Clinic Abu Dhabi, in collaboration with experts from Cleveland Clinic in the U.S., performed the world’s first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer.

April 25, 2025

Vol.51 No.16

Clinical Roundup

Gene-based blood test for melanoma may detect early signs of cancer return

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a recent study led by researchers at NYU Langone Health and its Perlmutter Cancer Center shows.

April 18, 2025

Vol.51 No.15

Clinical Roundup

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which patients with prostate cancer are at higher risk of developing long-lasting urinary side effects after receiving radiation therapy.

April 11, 2025

Vol.51 No.14

Urine test improves non-invasive detection of prostate cancer

YOU MAY BE INTERESTED IN

Shorter radiation therapy after prostate surgery safe, UCLA study finds

Quest Diagnostics report shows oncologists see more advanced cancers, say current tests not catching recurrence early enough

AI mapping technology outperforms MRI in predicting prostate cancer spread, study shows

Cleveland Clinic Abu Dhabi performs first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer

Gene-based blood test for melanoma may detect early signs of cancer return

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

Renew today!

Subscriber content

Never miss an issue!

Login